Journal
JOURNAL OF LIPID RESEARCH
Volume 52, Issue 12, Pages 2255-2261Publisher
ELSEVIER
DOI: 10.1194/jlr.M017681
Keywords
ATP-binding cassette transporter A1; apolipoprotein A-I; cholesterol; inflammation
Categories
Funding
- National Institutes of Health [P01HL086670]
- Lexington, KY Veterans Affairs Medical Center
Ask authors/readers for more resources
Inflammation is associated with significant decreases in plasma HDL-cholesterol (HDL-C) and apoA-I levels. Endothelial lipase (EL) is known to be an important determinant of HDL-C in mice and in humans and is up-regulated during inflammation. In this study, we investigated whether serum amyloid A (SAA), an HDL apolipoprotein highly induced during inflammation, alters the ability of EL to metabolize HDL. We determined that EL hydrolyzes SAA-enriched HDL in vitro without liberating lipid-free apoA-I. Coexpression of SAA and EL in mice by adenoviral vector produced a significantly greater reduction in HDL-C and apoA-I than a corresponding level of expression of either SAA or EL alone. The loss of HDL occurred without any evidence of HDL remodeling to smaller particles that would be expected to have more rapid turnover. Studies with primary hepatocytes demonstrated that coexpression of SAA and EL markedly impeded ABCA1-mediated lipidation of apoA-I to form nascent HDL. Our findings suggest that a reduction in nascent HDL formation may be partly responsible for reduced HDL-C during inflammation when both EL and SAA are known to be upregulated.-Wroblewski, J. M., A. Jahangiri, A. Ji, F. C. de Beer, D. R. van der Westhuyzen, and N. R. Webb. Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase. J. Lipid Res. 2011. 52: 2255-2261.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available